Zhang Lin, Pan Jifei, Dong Shibo, Li Zhaoming
a Department of Pharmaceutics, Shandong Academy of Pharmaceutical Sciences , Jinan , PR China.
b Shandong Provincial Engineering Research Center for Sustained-release Preparation of Chemical Drugs , Jinan , PR China.
J Drug Target. 2017 Sep;25(8):673-684. doi: 10.1080/1061186X.2017.1326123. Epub 2017 May 10.
Finding adequate carriers for proteins/peptides and anticancer drugs delivery has become an urgent need, owing to the growing number of therapeutic macromolecules and the increasing amount of cancer incidence. Polysaccharide-based nanogels have attracted interest as carriers for proteins/peptides and anticancer drugs because of their characteristic properties like biodegradability, biocompatibility, stimuli-responsive behaviour, softness and swelling to help achieve a controlled, triggered response at the target site. In addition, the groups of the polysaccharide backbone are able to be modified to develop functional nanogels. Some polysaccharides have the intrinsic ability to recognise specific cell types, allowing the design of targeted drug delivery systems through receptor-mediated endocytosis. This review is aimed at describing and exploring the potential of polysaccharides that are used in nanogels which can help to deliver proteins/peptides and anticancer drugs.
由于治疗性大分子数量的不断增加以及癌症发病率的日益上升,寻找合适的蛋白质/肽和抗癌药物载体已成为迫切需求。基于多糖的纳米凝胶因其具有生物可降解性、生物相容性、刺激响应行为、柔软性和膨胀性等特性,作为蛋白质/肽和抗癌药物的载体而受到关注,有助于在靶位点实现可控的触发反应。此外,多糖主链上的基团能够被修饰以开发功能性纳米凝胶。一些多糖具有识别特定细胞类型的内在能力,可通过受体介导的内吞作用设计靶向药物递送系统。本综述旨在描述和探索用于纳米凝胶的多糖的潜力,这些多糖有助于递送蛋白质/肽和抗癌药物。